The Future of Immune Checkpoint Inhibition in Gastric and Esophageal Cancers

Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.